Skip to main content

#151630

PDVC57B Cell Line

Cat. #151630

PDVC57B Cell Line

Cat. #: 151630

Sub-type: Continuous

Unit size: 1x10^6 cells / vial

Availability: 10-12 weeks

Organism: Mouse

Disease: Cancer

Model: Tumour line

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Allan Balmain

Institute: Cancer Research UK, Glasgow: The Beatson Institute

Tool Details
Target Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: PDVC57B Cell Line
  • Cancer: Carcinoma
  • Cancers detailed: Carcinoma Squamous Cell
  • Research fields: Apoptosis and autophagy;Cancer;Cell biology;Drug development;Genetics
  • Tool sub type: Continuous
  • Parental cell: PDV
  • Organism: Mouse
  • Disease: Cancer
  • Growth properties: Mouse spindle cell carcinoma, Adherent
  • Model: Tumour line
  • Description: The PDVC57B Cell Line is useful for the study of the progression of carcinogenesis and as a model of relapse after surgery. PDVC57B is syngeneic for C57B1/6 mice and carries a p53 mutation in codon 231, (ATG-GTC) and an A-T tranversion at cod 61 of the H-ras gene. These events appear to be remarkably similar to the sequence of changes seen during tumour development in vivo.
  • Production details: The transformed PDVB57B was created by treating the PDV cell line with the carcinogen DMBA.
  • Cellosaurus id: CVCL_4271

Target Details

  • Target: PDVC57b

Handling

  • Format: Frozen
  • Growth medium: DMEM + 2mM Glutamine + 10% Foetal Bovine Serum (FBS).
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice
  • Storage conditions: Vapor phase of liquid nitrogen. Storage at -70° C will result in loss of viability.
  • Subculture routine: Split sub-confluent cultures (70-80%) 1:5 to 1:10 i.e. seeding at 1-5x10,000 cells/cm² using 0.05% trypsin or trypsin/EDTA; 5% CO₂; 37°C

References

  • Oakley et al. 2002. Clin Cancer Res. 8(6):1984-1994. PMID: 12060644.
  • Quintanilla et al. 1991. Carcinogenesis. 12(10):1875-1881. PMID: 1934268.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.